Natural antimicrobial peptides against Mycobacterium tuberculosis

被引:53
作者
Abedinzadeh, Maria [1 ]
Gaeini, Mahdieh [1 ]
Sardari, Soroush [1 ]
机构
[1] Pasteur Inst Iran, Biotechnol Res Ctr, Med Biotechnol Dept, Drug Design & Bioinformat Unit, Tehran, Iran
关键词
tuberculosis; drug-resistant tuberculosis; antimycobacterial agents; toxicity; TB; CYANOBACTERIUM LYNGBYA-MAJUSCULA; HUMAN NEUTROPHIL PEPTIDE-1; IN-VITRO; NK-LYSIN; CYCLOPEPTIDE ALKALOIDS; EX-VIVO; ANTIMYCOBACTERIAL; CYCLODEPSIPEPTIDES; CYCLOHEXADEPSIPEPTIDES; IDENTIFICATION;
D O I
10.1093/jac/dku570
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
TB, caused by Mycobacterium tuberculosis, is one the leading infectious diseases worldwide. There is an urgent need to discover new drugs with unique structures and uncommon mechanisms of action to treat M. tuberculosis and combat antimycobacterial resistance. Naturally occurring compounds contain a wide diversity of chemical structures, displaying a wide range of in vitro potency towards M. tuberculosis. A number of recent studies have shown that natural antimycobacterial peptides can disrupt the function of the mycobacterial cell wall through different modes of action and thereafter interact with intracellular targets, including nucleic acids, enzymes and even organelles. More importantly, the probability of antimycobacterial resistance is low. This review presents several natural antimicrobial peptides isolated from different organism sources, including bacteria, fungi, plants and animals. In addition, the molecular features of these molecules are the subject of much attention. Such peptides have common traits among their chemical features, which may be correlated with their biological activities; hence, different parts of the molecular structures can be modified in order to increase penetration into the target cells. This review also summarizes the available information on the properties of antimycobacterial peptides associated with their biological activities.
引用
收藏
页码:1285 / 1289
页数:5
相关论文
共 54 条
[1]   Identification of an anti-mycobacterial domain in NK-lysin and granulysin [J].
Andreu, D ;
Carreño, C ;
Linde, C ;
Boman, HG ;
Andersson, M .
BIOCHEMICAL JOURNAL, 1999, 344 :845-849
[2]   Bioprospecting for antituberculosis leads from microbial metabolites [J].
Ashforth, Elizabeth Jane ;
Fu, Chengzhang ;
Liu, Xiangyang ;
Dai, Huanqin ;
Song, Fuhang ;
Guo, Hui ;
Zhang, Lixin .
NATURAL PRODUCT REPORTS, 2010, 27 (11) :1709-1719
[3]   Solid-phase total synthesis of kahalalide A and related analogues [J].
Bourel-Bonnet, L ;
Rao, KV ;
Hamann, MT ;
Ganesan, A .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (05) :1330-1335
[4]   Comparison of the activities of the lantibiotics nisin and lacticin 3147 against clinically significant mycobacteria [J].
Carroll, James ;
Draper, Lorraine A. ;
O'Connor, Paula M. ;
Coffey, Aidan ;
Hill, Colin ;
Ross, R. Paul ;
Cotter, Paul D. ;
O'Mahony, Jim .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2010, 36 (02) :132-136
[5]   Antimycobacterial natural products [J].
Copp, BR .
NATURAL PRODUCT REPORTS, 2003, 20 (06) :535-557
[6]   The Future of Peptide-based Drugs [J].
Craik, David J. ;
Fairlie, David P. ;
Liras, Spiros ;
Price, David .
CHEMICAL BIOLOGY & DRUG DESIGN, 2013, 81 (01) :136-147
[7]   Microcionamides A and B, bioactive peptides from the Philippine sponge Clathria (Thalysias) abietina [J].
Davis, RA ;
Mangalindan, GC ;
Bojo, ZP ;
Antemano, RR ;
Rodriguez, NO ;
Concepcion, GP ;
Samson, SC ;
de Guzman, D ;
Cruz, LJ ;
Tasdemir, D ;
Harper, MK ;
Feng, XD ;
Carter, GT ;
Ireland, CM .
JOURNAL OF ORGANIC CHEMISTRY, 2004, 69 (12) :4170-4176
[8]   Designing antimicrobial peptides: form follows function [J].
Fjell, Christopher D. ;
Hiss, Jan A. ;
Hancock, Robert E. W. ;
Schneider, Gisbert .
NATURE REVIEWS DRUG DISCOVERY, 2012, 11 (01) :37-51
[9]  
Fu LM, 2003, INT J TUBERC LUNG D, V7, P1027
[10]   Recent advances in antitubercular natural products [J].
Garcia, Abraham ;
Bocanegra-Garcia, Virgilio ;
Prisco Palma-Nicolas, Jose ;
Rivera, Gildardo .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2012, 49 :1-23